ATE304860T1 - Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung - Google Patents

Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung

Info

Publication number
ATE304860T1
ATE304860T1 AT02745002T AT02745002T ATE304860T1 AT E304860 T1 ATE304860 T1 AT E304860T1 AT 02745002 T AT02745002 T AT 02745002T AT 02745002 T AT02745002 T AT 02745002T AT E304860 T1 ATE304860 T1 AT E304860T1
Authority
AT
Austria
Prior art keywords
extract
thylacoids
inflammatory
compositions containing
modulating inflammation
Prior art date
Application number
AT02745002T
Other languages
English (en)
Inventor
Alain Andersen
Elyse Bissonnette
Rejean Drouin
Marc Purcell
Original Assignee
Purecell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002381830A external-priority patent/CA2381830A1/en
Application filed by Purecell Technologies Inc filed Critical Purecell Technologies Inc
Application granted granted Critical
Publication of ATE304860T1 publication Critical patent/ATE304860T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02745002T 2001-07-02 2002-07-02 Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung ATE304860T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30183201P 2001-07-02 2001-07-02
CA002381830A CA2381830A1 (en) 2002-04-15 2002-04-15 Compositions comprising thylakoids useful in the modulation of the inflammation process
PCT/CA2002/001009 WO2003004042A1 (en) 2001-07-02 2002-07-02 Compositions comprising thylakoids useful in the modulation of the inflammation process

Publications (1)

Publication Number Publication Date
ATE304860T1 true ATE304860T1 (de) 2005-10-15

Family

ID=25682856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745002T ATE304860T1 (de) 2001-07-02 2002-07-02 Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung

Country Status (6)

Country Link
US (1) US7329423B2 (de)
EP (1) EP1401463B1 (de)
JP (2) JP4988144B2 (de)
AT (1) ATE304860T1 (de)
DE (1) DE60206270T2 (de)
WO (1) WO2003004042A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2535208C (en) 2003-09-22 2013-11-26 Purecell Technologies Inc. Oral compositions and route of administration for the delivery of a thylakoid extract
HUE040501T2 (hu) * 2005-06-10 2019-03-28 Thylabisco Ab Növényi sejtmembrán alkalmazása elhízás kezelésére
WO2007109893A1 (en) * 2006-03-27 2007-10-04 Les Technologies Biofiltre Inc. Plant extracts and uses thereof
JP5602164B2 (ja) * 2010-01-26 2014-10-08 株式会社日清製粉グループ本社 抗炎症剤
CA2699676C (en) * 2010-04-12 2018-07-17 Purgenesis Technologies Inc. The use of a photosynthetic cell extract in a cosmetic composition
GB201304626D0 (en) * 2013-03-14 2013-05-01 Univ Cardiff Method of identifying a bacterial infection
EP3370749A4 (de) 2015-11-03 2019-08-21 Groupe Santé Devonian Inc. Thylakoid-extrakt-zusammensetzung und formulierung zur behandlung von entzündlichen darmerkrankungen
EP3534924A4 (de) * 2016-11-04 2020-07-01 Groupe Santé Devonian Inc. Zusammensetzung zur vorbeugung und/oder behandlung von herz-kreislauf-erkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2293852A1 (fr) * 1999-12-30 2001-06-30 Purecell Technologies Inc. Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant

Also Published As

Publication number Publication date
JP2009298810A (ja) 2009-12-24
DE60206270D1 (de) 2006-02-02
WO2003004042A1 (en) 2003-01-16
EP1401463B1 (de) 2005-09-21
US7329423B2 (en) 2008-02-12
DE60206270T2 (de) 2006-08-17
US20050048148A1 (en) 2005-03-03
JP4988144B2 (ja) 2012-08-01
JP2004535458A (ja) 2004-11-25
EP1401463A1 (de) 2004-03-31

Similar Documents

Publication Publication Date Title
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
ATE357509T1 (de) Stimulierung von hämatopoietischen zellen im vitro
CR6883A (es) Composiciones farmaceuticas de inhibidores de la potencia de colesteril ester
BR0317715A (pt) Composições e processos de uso de collajolie
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
EA200301018A1 (ru) Доставляемая перорально фармацевтическая композиция, включающая активное соединение, содержащее аминосульфонильную группу (ингибитор cox-2), полиэтиленгликоль и улавливающий свободные радикалы антиоксидант
DK0730465T3 (da) Anvendelse af angiotensin III og analoger dertil til vævsreparation
ATE274330T1 (de) Gleitschutz fur einen gehäusekopf medizinischer instrumente
ATE196844T1 (de) Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
WO2007038686A3 (en) Amniotic membrane preparations and purified compositions and methods of use
EA199900448A1 (ru) Производные 6-фенилпиридил-2-амина, полезные в качестве ингибиторов nos
ATE304860T1 (de) Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
DK1019490T3 (da) Fremgangsmåder til modulering af hæmatopoese og vaskulær vækst
PT1032414E (pt) Combinacao de um inibidor da enzima de conversao da angiotensina e de um diuretico para o tratamento de perturbacoes microcirculatorias
BR9711046A (pt) Ligando relacionado a fator de necrose de tumor.
ES2188870T3 (es) Sustrato compuesto elastomero selectivamente conductor segun el eje z, reutilizable.
DE60234463D1 (de) Abgabe von hydrogel-zusammensetzungen aus feinsprühnebel
DE60141636D1 (de) Phospholipidderivate von valproinsäure und ihre kombinationen
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
DK0912185T3 (da) Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler
EA200000165A1 (ru) Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos
ES2111175T3 (es) Piperazinas 1,4-disustituidas utiles en el tratamiento del asma y de inflamaciones de las vias respiratorias.
CA2359491A1 (en) Mixture of plant treatment compositions with waxes, their preparation, and their use
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties